Articular chondral and osteochondral injuries of the knee are common in people aged under 35 years, and sympto matic lesions left untreated may lead to chronic pain and disability. Patients with articular chondral injuries often have a poorer function score than those awaiting surgery for other knee disorders, such as osteoarthritis or a rup tured anterior cruciate ligament. 1 Patients with articular cartilage injuries may go on to develop early onset osteo arthritis with long term morbidity and consequent high use of health service resources; successful early treatment of these lesions would probably be cost effective.
Chondral and osteochondral lesions may not be diag nosed or may present late because patients will often give a history of an apparent insignificant trauma and doc tors may fail to understand the importance of an effusion in the knee joint, which always indicates joint disease.
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Radiographs of the knee may be poorly interpreted. This review discusses the diagnosis and management (con servative and surgical) of injuries to the articular cartilage of the knee and draws on published research articles and the authors' own experience.
Methods
We searched the Cochrane database, PubMed, and Google Scholar up to December 2009. We analysed randomised controlled trials and comparison trials, as well as articles on operative technique and case series.
How are articular chondral injuries of the knee classified?
Long bone articular surfaces are covered with hyaline cartilage. Damage to this hyaline cartilage is known as a chondral injury or, if the underlying bone is also frac tured, an osteochondral injury.
Articular cartilage is avascular and aneural, so pain would not be expected. Yet some patients with chondral lesions do present with pain. A widely accepted hypoth esis for the presence of this pain is that it is caused by the increased load on the subchondral bone resulting from damage or loss of overlying cartilage.
The problems with articular cartilage are that it has little capacity to repair itself or regenerate intrinsi cally.
3 w1 w2 Therefore cartilage defects repair by form ing scar tissue from the subchondral bone. This scar tissue is deficient in type II collagen and has "abnor mal" proteoglycans (which have inferior biomechanical characteristics) and lower load bearing capacity, and its formation will often result in short term recovery. This later surface deterioration may progress to give chronic pain and poor function and may in some cases lead to early onset osteo arthritis.
w3 w4
who gets articular chondral injuries of the knee? A regional database study of over 30 000 patients found that 63% of knees that undergo arthroscopy are found to have disease in the articular cartilage 5 and articular chondral lesions are suspected to be the cause of as many as 10% of all knee haemarthroses.
6
Trauma is the most common aetiology, 6 w5 but other conditions, such as osteochondritis dissecans 7 w6 and chondromalacia patellae (abnormal softening of the patel lar articular cartilage), 8 w7 are also accepted as causes of symptomatic painful articular lesions. Isolated articular cartilage injuries secondary to trauma are rare; more often articular cartilage injuries are seen with other traumatic injuries to the knee, such as ligamentous or meniscal damage.
w8
A recent magnetic resonance imaging study found that after acute trauma the most common injuries to the imma ture knee were chondral in nature.
9
Osteochondral lesions are most common in adoles cents w9 as the cartilage has yet to calcify. Traumatic forces are transmitted through the subchondral bone beneath the cartilage, resulting in an osteochondral fracture.
How do you make a diagnosis?
Patients with symptoms present with a painful knee. Pain may be present at rest and is exacerbated by weight bearing exercises. The knee may give way if a longstand ing injury results in substantial muscle wasting or there is associated ligamentous instability. Locking is seen if a loose osteochondral fragment impedes articular m ovement.
The most common findings on examination are tender ness on palpation of the joint line, with pain induced by both passive and active movements. The examiner will see wasting of the quadriceps and feel crepitus on passive
SuMMaRy pointS
Articular cartilage injuries of the knee are common in people aged under 35 years If symptomatic they can be debilitating and may progress to osteoarthritis Early appropriate treatment of symptomatic lesions may prevent the onset of osteoarthritis and is cost effective CliniCal Review joint movement in a usually stable knee. These clinical findings are not specific to chondral and osteochondral lesions.
The optimal assessment of articular injuries of the knee remains the examination of the knee under anaesthesia followed by arthroscopy; this allows for direct visualisa tion to establish the size, site, and depth of the chondral lesion and the ligamentous integrity of the knee.
Other diagnostic tools include magnetic resonance imaging, which provides accuracy with high levels of reproducibility.
w10 w11 Delayed, gadolinium enhanced magnetic resonance imaging of cartilage (dGEMRIC) visu alises the glycosaminoglycan content of the cartilage and is useful in diagnosing early osteoarthritis and cartilage health. How are injuries of the articular cartilage treated? conservative management Animal studies have shown that continuous passive motion enhances the healing potential of articular carti lage. It has two potential mechanisms of action. Firstly, it enables the movement of synovial fluid, allowing better diffusion of nutrients into damaged cartilage and diffu sion out of other materials (such as blood and metabolic waste products). Secondly, it reduces the formation of fibrous scar tissue in the joint; this tends to decrease the range of motion for a joint, which enhances the healing potential of articular cartilage.
w13 Although animal models showed satisfactory results, the healing noted was much less pronounced in lesions greater than 3 mm 2 .
10
What are the indications for surgery? Little evidence exists for the need to treat asymptomatic defects that are found incidentally. However, there are animal and cadaveric studies suggesting that defects larger than 6 mm will not heal spontaneously.
w14
In general, injuries that are new are given time to set tle to see if the chondral lesion will become symptomatic or not. Observational evidence suggests that after the initial acute phase, if pain fails to resolve, surgical treat ment gives better outcomes if done sooner rather than later.
1214
Treatment of larger and symptomatic lesions is surgi cal. Interventions that have been investigated and used are arthroscopic debridement, marrow stimulating tech niques, autologous chondrocyte transfers and implanta tion, and allografts.
Ideally the aim of surgery is to provide an environment that allows whatever repair tissue is produced (preferably hyaline cartilage) to be integrated with native healthy tis sue to provide long term durability and a "normal" knee joint.
w15 w16 arthroscopic debridement Arthroscopic debridement involves removal of fragments of loose cartilage to provide temporary symptomatic relief. Relief is only transient as the washout clears inflamma tory debris but does not treat the underlying articular cartilage injury. A randomised controlled study found that painful symptoms usually return within five years and continued chondral deterioration occurs within the affected joint. 
Marrow stimulating techniques (reparative) Abrasion chondroplasty
The aim of abrasion chondroplasty is to induce fibro cartilage growth into the chondral defect by causing a "therapeutic" bleeding, resulting in a clot that forms fibrocartilage. Johnson reviewed the literature and his own case series and found that chondroplasty improved symptoms in the first 12 months postoperatively, although a return to preoperative symptoms was often seen beyond 24 months (this return to previous symptoms, however, was in an older population with established arthritic changes). Bone drilling Bone drilling, first described in 1959 as a method of resurfacing osteoarthritic knees, w18 is now practised as a technique to stimulate reparative growth of damaged or missing articular cartilage. Holes of 22.5 mm diam eter are drilled into the subchondral layer of bone in the defect. Drilling results in substantial thermal heat, which has been suggested as causing damage to the subchon dral bone, thus impeding healing. This hypothesis, how ever, has never been proved. Bone drilling is an open arthrotomy procedure and hence has higher morbidity compared with other marrow stimulating techniques that can be performed arthroscopically. Drilling has now largely been superseded by other techniques.
Microfracture
Microfracture (fig 1) involves the perforation of the subchondral bone using a sharp awl. The technique, first described in 1997, is a refined form of bone drill ing. The aim is to release pluripotent stem cells from within the subchondral bone along with growth factors and cytokines, thus producing a clot rich in regenerative cells, an ideal environment for fibrocartilage repair.
w19
Unlike drilling, microfracture does not produce enough heat to damage subchondral bone and is almost always performed arthroscopically. A randomised controlled study suggested that microfracture produces equivalent results to its more expensive alternatives for as long as five years. 17 However, the technique produces fibrocarti lage that does not possess the same properties as the lost hyaline cartilage and that may not have the longevity of hyaline type cartilage.
18 w20 Best results have been shown in slim athletic patients 17 w21 w22 with microfracture of the femoral condyle.
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A recent cohort study has shown disturbing changes in the subchondral bone after microfracture; these include increased density and cyst formation, which delay heal ing and impede the load bearing function of the articular cartilage.
autologous transfers and implantation
Osteochondral autograft transplantation Osteochondral autograft transplantation (also known as mosaicplasty) involves the transplantation of osteo chondral grafts from a nonweight bearing area of the knee and transplanting them into the acquired defect (fig 2) . Such transplantations were first described in 1985 w23 and made popular by Hangody in 1997. w24 Small cylinders (4.5 
CliniCal Review
Autologous chondrocyte implantation Autologous chondrocyte implantation (fig 3) has been widely investigated as it may offer the best hope for repair tissue that is most similar to the articular hyaline cartilage that has been lost. Some randomised controlled comparisons and case series have reported good results using autologous chondrocyte implantation or some form of derivative of the procedure.
13 24 26 w27 Two randomised controlled studies have compared the clinical outcome of autologous chondrocyte implantation versus osteo chondral autograft transplantation. The first study (100 patients) found better clinical outcomes with autologous chondrocyte implantation, 24 whereas the second study (40 patients) (evidence level II2 according to the US Pre ventive Services Task Force's ranking system) found no difference in clinical outcome after two years between the two procedures. A randomised comparison of autologous chondrocyte implantation with microfracture found similarly favour able clinical outcomes for both procedures up to five years after surgery. 17 However, a multicentre prospective com parison found better filling of the defect with autologous chondrocyte implantation than with microfracture, and improved clinical results. 27 Magnetic resonance imaging and histological analysis suggest that a better quality of repair material is achieved with autologous chondrocyte implantation than with microfracture. 17 26 The primary aim of autologous chondrocyte implanta tion is to produce repair material that resembles hyaline cartilage. However, histological analysis of implanted grafts has suggested that many biopsies show fibrocar tilage and mixed fibrohyaline cartilage. A comparative study of autologous chondrocyte implantation and micro fracture found that the formation of this fibrous material is due to the change of cell phenotype during cell expan sion and therefore the loss of chondrogenic potential of the implanted cells. This finding has led to the develop ment of "characterised" chondrocytes that are labelled as "stable" phenotypic cells, increasing the chances of the cells maintaining their chondrogenic potential. A study series has shown a better histological profile though not one clinically superior to microfracture. 26 Most graft biop sies taken in a variety of studies have been at 12 months. Histological assessment has suggested that biopsies of grafts are taken too early and that the graft undergoes a maturation process over two years. 28 Subsequently stud ies have found significant evidence between the timing of biopsies of grafts, histological outcome, and clinical results, with indications that the graft continues to mature into a more hyalinetype cartilage beyond the initial 12 month stage.
29 Figure 4 shows a typical flow diagram from initial assessment of a referred patient with suspected knee chondral cartilage injury to treatment and followup.
Osteochondral allografts
Allografts have been used in the treatment of large chon dral and osteochondral defects since the 1970s: articular cartilage is harvested from cadavers and implanted into the chondral or osteochondral defect. Prospective cohort studies have shown good results with this technique.
w29 In the United Kingdom, obtaining allografts is difficult and a small risk of disease transmission exists. who is the best candidate for surgery? Microfracture has reported good results in all age groups that it has been performed on. Steadman and colleagues, however, reported better results in those aged under 35 years, w30 and this finding has been echoed in studies of autologous chondrocyte implantation. 12 Increasing body mass index also shows a poorer correlation to success in both microfracture and autologous chondrocyte implan tation, 12 30 as does smoking.
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Which treatment?
The ideal treatment of symptomatic chondral lesions would be an efficacious procedure that provides long term results with reduced morbidity and swift recovery, The current evidence does not confirm which of the current surgical procedures is best, although evidence is sufficient to support marrow stimulating techniques and autologous restorative techniques. Some surgeons advocate marrow stimulating techniques because of the ease of the procedure, its "one step" nature, reduced knee morbidity (since it can be performed arthroscopically), and relatively low cost. On the other hand, if marrow stimulating techniques have a limited longevity and a potential risk of damaging the subchondral bone it would be more beneficial to pursue restorative autologous cel lular techniques despite the relatively large cost of the procedure.
ONGOING RESEARCH
In the 1990s a prospective study of 44 patients having autologous chondrocyte implantation for full thickness cartilage lesions examined the efficacy of treatment and quality of life and calculated the average cost per addi tional quality adjusted life year. The authors concluded that autologous chondrocyte implantation improves patients' quality of life and is therefore an appropri ate, cost effective treatment for cartilage lesions of the knee. 32 However, more recently an analysis of data from randomised trials and observational studies has found insufficient evidence to show that autologous chondro cyte implantation is more cost effective than microfrac ture. This study did, however, show that long term results are not available but would be necessary for evaluating long term cost effectiveness.
33

Conclusion
The current most effective management of chondral and osteochondral lesions of the knee is early diagnosis, rapid referral, and prompt treatment of serious symptomatic lesions.
Long term success must be considered in the treatment of these lesions to prevent potential early osteoarthritic changes. An early "fix" with a marrow stimulating tech nique may seem an attractive midterm option, but if the repair material breaks down, leaving a knee that is in worse condition, then further surgery may be needed in the long term, with associated cost implications.
Case studies describing how early intervention with autologous chondrocyte implantation in adolescents improved their ability to return to preinjury level activity 14 show promise, in contrast to reports that failed marrow stimulating treatments reduce the rate of long term suc cess of autologous chondrocyte implantation. 12 13 Currently in the UK autologous chondrocyte implanta tion is considered only after there has been a failed "con ventional" treatment (microfracture, drilling, abrasion).
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In areas of Europe and in the United States chondrocyte implantation is offered as a first line treatment, with excellent results in those patient groups.
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